On November 4, International Flavors & Fragrances Inc. (IFF), a global fragrance and flavor giant, released its financial results for the third quarter of fiscal year 2025.
According to the report, IFF recorded sales of $2.7 billion for the third quarter, down 8 percent year over year. Adjusted operating EBITDA came to $519 million. For the first nine months of the year, sales totaled $8.3 billion, with adjusted operating EBITDA reaching $1.6 billion.
IFF operates four main business segments: Taste, Health & Biosciences, Food Ingredients, and Scent. In the third quarter, all segments posted growth except Food Ingredients, which saw a slight decline. Among them, the Scent division delivered particularly strong results.
Specifically, the Scent division—which includes fine fragrances and consumer fragrances—generated $652 million in sales, up 6 percent year over year, with adjusted operating EBITDA of $135 million. Fine fragrance posted robust growth of 20 percent, while consumer fragrances achieved low single-digit growth. Sales of fragrance ingredients declined slightly, as growth in specialty ingredients was offset by declines in commodity materials.
The Health & Biosciences division reported sales of $577 million for the third quarter, up 2 percent year over year, and adjusted operating EBITDA of $150 million. Growth in the home and personal care categories was partly offset by declines in the health business, particularly in North America.
“In a challenging operating environment, our third-quarter results remained solid, with profit margins achieving high single-digit growth year over year,” said IFF Chief Executive Officer Erik Fyrwald. He added that the company would maintain its full-year outlook and continue advancing portfolio optimization initiatives to unlock its full potential and deliver lasting value.
IFF expects full-year 2025 sales to be between $10.6 billion and $10.9 billion, with adjusted operating EBITDA ranging from $2.0 billion to $2.15 billion.
